REQUEST A DEMO
Total
USD $0.00
Search more companies

Pmup Apteka N458 (Russia)

Main Activities: Pharmacies and Drug Stores
Full name: Pmup Apteka N458 Profile Updated: August 17, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Russian Download a sample report

Pmup Apteka N458 is a company in Russia, with a head office in Pervouralsk. The enterprise operates in the Pharmacies and Drug Stores industry. It was established on March 19, 1993. In its most recent financial highlights, the company reported a net sales revenue increase of 18.39% in 2022. There was a total growth of 15.24% in Pmup Apteka N458’s total assets over the same period. The net profit margin of Pmup Apteka N458 increased by 0.14% in 2022.

Headquarters
Komsomoliskaya, 15 A
Pervouralsk; Sverdlovsk Oblast; Postal Code: 623104

Contact Details: Purchase the Pmup Apteka N458 report to view the information.

Basic Information
Outstanding Shares:
Purchase the Pmup Apteka N458 report to view the information.
Registered Capital:
Purchase the Pmup Apteka N458 report to view the information.
Incorporation Date:
March 19, 1993
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Pmup Apteka N458 report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
18.39%
Total operating revenue
18.39%
Operating profit (EBIT)
28.14%
Net Profit (Loss) for the Period
32.48%
Total assets
15.24%
Total equity
11.79%
Operating Profit Margin (ROS)
0.2%
Net Profit Margin
0.14%
Return on Equity (ROE)
2.13%
Quick Ratio
0.05%
Cash Ratio
0.1%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?